Assessment of tailor-made HPMC-based matrix minitablets comprising a weakly basic drug compound

Drug Development and Industrial Pharmacy

Volumn 34, Issue 1, 2008, Pages 46-52

  Siepe, Stefanie ^a,b   Lueckel, Barbara ^a   Kramer, Andrea ^a   Ries, Angelika ^a   Gurny, Robert ^b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Dipyridamole; HPMC; Minitablets; Molecular weight; pH modifier; Weakly basic drug

Indexed keywords

DIPYRIDAMOLE; FUMARIC ACID; METHYLCELLULOSE; SUCCINIC ACID;

ARTICLE; DRUG RELEASE; MICROENVIRONMENT; PH; TABLET;

CHEMISTRY, PHARMACEUTICAL; DIPYRIDAMOLE; FUMARATES; HYDROGEN-ION CONCENTRATION; METHYLCELLULOSE; MOLECULAR WEIGHT; SOLUBILITY; SUCCINIC ACID; TABLETS;

EID: 38549103525     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040701484106     Document Type: Article

References (22)

1. Abrahamsson, B., Alpsten, M., Jonsson, U. E., Lundberg, P. J., Sandberg, A., Sundgren, M., Svenheden, A., & Tolli, J. (1996). Gastro-intestinal transit of a multiple-unit formulation (metoprolol cr/zok) and a non-disintegrating tablet with the emphasis on colon. Int. J. Pharm., 140, 229-235. 10.1016/0378-5173(96)04604-2
2. Bechgaard, H. (1982). Critical factors influencing gastrointestinal absorption - What is the role of pellets. Acta Pharm. Technol., 28, 149-157. www.uni-duesseldorf.de/kojda-pharmalehrbuch/apothekenmagazin/ Fortbildungsartikel/2005-06.pdf
3. Campos-Aldrete, M. E., & Villafuerte-Robles, L. (1997). Influence of the viscosity grade and the particle size of hpmc on metronidazole release from matrix tablets. Eur. J. Pharm. Biopharm., 43, 173-178. 10.1016/S0939-6411(96)00004-5
4. Davis, S. S., Hardy, J. G., Taylor, M. J., Whalley, D. R., & Wilson, C. G. (1984). The effect of food on the gastrointestinal transit of pellets and an osmotic device (osmet). Int. J. Pharm., 21, 331-340. 10.1016/0378-5173(84)90191-1
5. Davis, S. S., Khosla, N., Wilson, C. G., & Washington, N. (1987). A comparative study of the gastrointestinal transit of a pellet and tablet formulation. Int. J. Pharm., 35, 253-258. www.springerlink.com/index/ GL00177T62488757.pdf
6. De Brabander, C., Vervaet, C., Fiermans, L., & Remon, J. P. (2000). Matrix minitablets based on starch/microcrystalline wax mixtures. Int. J. Pharm., 199, 195-203. 10.1016/S0378-5173(00)00383-5
7. Espinoza, R., Hong, E., & Villafuerte, L. (2000). Influence of admixed citric acid on the release profile of pelanserin hydrochloride from hpmc matrix tablets. Int. J. Pharm., 201, 165-173. 10.1016/S0378-5173(00) 00406-3
8. Follonier, N., & Doelker, E. (1992). Biopharmaceutical comparison of oral multiple-unit and single-unit sustained-release dosage forms. S. T. P. Pharma Sci., 2, 141-158. www.aapspharmscitech.org/view.asp?art=pt070246
9. Gabr, K. E. (1992). Effect of organic acids on the release patterns of weakly basic drugs from inert sustained release matrix tablets. Eur. J. Pharm. Biopharm., 38, 199-202. linkinghub.elsevier.com/retrieve/pii/ S0378517305002966
10. Gao, P., Skoug, J. W., Nixon, P. R., Ju, T. R., Stemm, N. L., & Sung, K. C. (1996). Swelling of hydroxypropyl methylcellulose matrix tablets. 2. Mechanistic study of the influence of formulation variables on matrix performance and drug release. J. Pharm. Sci., 85, 732-740. 10.1021/Js9504595
11. Hörter, D., & Dressman, J. D. (1997). Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv. Drug Deliver. Rev., 25, 3-14. 10.1016/S0169-409x(96)00487-5
12. Kohri, N., Miyata, N., Takahashi, M., Endo, H., Iseki, K., Miyazaki, K., Takechi, S., & Nomura, A. (1992). Evaluation of ph-independent sustained-release granules of dipyridamole by using gastric-acidity-controlled rabbits and human subjects. Int. J. Pharm., 81, 49-58. 10.1016/0378-5173(92)90042-Z
13. Lelawongs, P., Barone, A., Colaizzi, L., & Guarnieri, J. (1988). Effect of food and gastric acidity on absorption of orally administered ketoconazole. Clin. Pharm., 7, 228-235. www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=162805
14. Munday, D. L. (2003). Film coated pellets containing verapamil hydrochloride: enhanced dissolution into neutral medium. Drug Dev. Ind. Pharm., 29, 575-583. 10.1081/Ddc-120018646
15. Nie, S., Pan, W., Li, X., & Wu, X. (2004). The effect of citric acid added to hydroxypropyl methylcellulose (hpmc) matrix tablets on the release profile of vinpocetine. Drug Dev. Ind. Pharm., 30, 627-635. 10.1081/Ddc-120037664
16. Stahl, P. H., Wermuth, C. G. (2002). Handbook of Pharmaceutical Salts: Properties, Selection and Use. Wiley Vch Verlag Gmbh. www.iupac.org/ publications/books/year/index.html
17. Streubel, A., Siepmann, J., Dashevsky, A., & Bodmeier, R. (2000). Ph-independent release of a weakly basic drug from water-iInsoluble and -soluble matrix tablets. J. Control. Release, 67, 101-110. 10.1016/S0168-3659(00) 00200-5
18. Tahara, K., Yamamoto, K., & Nishihata, T. (1995). Overall mechanism behind matrix sustained release (sr) tablets prepared with hydroxypropyl methylcellulose 2910. J. Control. Rel., 35, 59-66. 10.1016/0168-3659(95) 00021-Y
19. Terhaag, B., Donath, F., Le Petit, G., & Feller, K. (1986). The absolute and relative bioavailability of diypridamole from different preparations and the in vitro-in vivo comparison. Int. J. Clin. Pharmacol. Therapeut., 24(6), 298-302. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd= Retrieve&db=PubMed&list_uids=3733279&dopt=Abstract
20. Thoma, K., & Ziegler, I. (1997). The ph-independent release of fenoldopam from pellets with insoluble film coats. Eur. J. Pharm. Biopharm., 46, 105-113. 10.1016/S0939-6411(97)00164-1
21. Varma, M. V. S., Kaushal, A. M., & Garg, S. (2005). Influence of microenvironmental ph on the gel layer behavior and release of a basic drug from various hydrophilic matrices. J. Control. Rel., 103, 499-510. 10.1016/J.Jconrel.2004.12.015
22. Zhou, R., Moench, P., Heran, C., Lu, X. J., Mathias, N., Faria, T. N., Wall, D. A., Hussain, M. A., Smith, R. L., & Sun, D. X. (2005). Ph-dependent dissolution in vitro and absorption in vivo of weakly basic drugs: Development of a canine model. Pharm. Res., 22, 188-192. 10.1007/S11095-004-1185-3